Literature DB >> 18480991

A comparative study on proteomics between LNCap and DU145 cells by quantitative detection and SELDI analysis.

Weigui Sun1, Zhangqun Ye, Zhenguo Mi, Tianliang Shi, Cunzhi Han, Sutang Guo.   

Abstract

The differences in intracellular and extracellular protein expressions between human prostate cancer lines LNCap and DU145 were examined. The proteins of the two cell lines were extracted and condensed by using protein extraction kits. And the intracellular and extracellular proteins were quantitatively detected on a micro-plate reader by using bicinchoninic acid (BCA) method. The proteins in cell culture fluid were qualitatively assayed by SELDI-TOF-MS. The results showed that the intracellular protein contents of LNCap cells were extremely higher than those of DU145 cells. After serum-free culture, both intracellular and extracellular protein contents of LNCap and DU145 were decreased to some extent. And the intracellular proteins were decreased by 5% in LNCap and by 36% in DU145 respectively, while the extracellular proteins were decreased by 89% in LNCap and 96% in DU145 respectively. SELDI assay revealed that there were 5 marker proteins in LNCap and 6 in DU145. Although both LNCap and DU145 cell lines originated from human prostate cancer, they had some differences in protein expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480991     DOI: 10.1007/s11596-008-0215-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  14 in total

1.  Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.

Authors:  Judith Y M N Engwegen; Helgi H Helgason; Annemieke Cats; Nathan Harris; Johannes M G Bonfrer; Jan H M Schellens; Jos H Beijnen
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

2.  Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer.

Authors:  Yu-Zhuo Pan; Xue-Yuan Xiao; Dan Zhao; Ling Zhang; Guo-Yi Ji; Yang Li; Bao-Xue Yang; Da-Cheng He; Xue-Jian Zhao
Journal:  Asian J Androl       Date:  2006-01       Impact factor: 3.285

3.  SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer.

Authors:  Asa Skytt; Elin Thysell; Pär Stattin; Ulf-Håkan Stenman; Henrik Antti; Pernilla Wikström
Journal:  Int J Cancer       Date:  2007-08-01       Impact factor: 7.396

Review 4.  Proteomics in prostate cancer research.

Authors:  Magnus Hellström; Helena Lexander; Bo Franzén; Lars Egevad
Journal:  Anal Quant Cytol Histol       Date:  2007-02       Impact factor: 0.302

Review 5.  Growth factors involved in prostate carcinogenesis.

Authors:  Suman Kambhampati; Gibanananda Ray; Krishanu Sengupta; Venkataprasanth P Reddy; Sushanta K Banerjee; Peter J Van Veldhuizen
Journal:  Front Biosci       Date:  2005-05-01

6.  Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) for determining prognosis in advanced stage hormone relapsing prostate cancer.

Authors:  Manish Kohli; Eric Siegel; Sudeepa Bhattacharya; Mir Alikhan Khan; Rajesh Shah; Larry J Suva
Journal:  Cancer Biomark       Date:  2006       Impact factor: 4.388

7.  Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer.

Authors:  Gunjan Malik; Michael D Ward; Saurabh K Gupta; Michael W Trosset; William E Grizzle; Bao-Ling Adam; Jose I Diaz; O John Semmes
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

8.  Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.

Authors:  Yuhyun Park; Sean R Downing; Dohyun Kim; William C Hahn; Cheng Li; Philip W Kantoff; L J Wei
Journal:  Bioinformatics       Date:  2007-04-25       Impact factor: 6.937

9.  Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutine.

Authors:  Rita Ghosh; Gretchen E Garcia; Katherine Crosby; Hiroyasu Inoue; Ian M Thompson; Dean A Troyer; Addanki P Kumar
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

10.  Transforming growth factor-beta 1 gene polymorphisms and expression in the blood of prostate cancer patients.

Authors:  Paula Cristina Faria; Karla Saba; Adriana Freitas Neves; Elisangela Rosa Cordeiro; Karina Marangoni; Danielo Garcia Freitas; Luiz Ricardo Goulart
Journal:  Cancer Invest       Date:  2007-12       Impact factor: 2.176

View more
  1 in total

1.  Reproducibility of SELDI Spectra Across Time and Laboratories.

Authors:  Lixia Diao; Charlotte H Clarke; Kevin R Coombes; Stanley R Hamilton; Jack Roth; Li Mao; Bogdan Czerniak; Keith A Baggerly; Jeffrey S Morris; Eric T Fung; Robert C Bast
Journal:  Cancer Inform       Date:  2011-03-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.